Literature DB >> 16248238

[Observation on effect of compound danshen droplet-pill combined with trimetazidine in treating senile unstable angina pectoris].

Zhong-xia Qiu1, He-jun Ma, Di-fei Wang.   

Abstract

OBJECTIVE: To investigate the effect of compound Danshen Droplet-pill (DS) combined with trimetazidine (TMZ) in treating senile unstable angina pectoris (SUAP).
METHODS: One hundred and twenty patients with SUAP were eaually and randomly divided into 2 groups, the treated group and the control group. Changes of angina, occurrence of arrhythmia, myocardial infarction and sudden death, myocardial ischemia in ECG and partial indexes of heart function were observed.
RESULTS: The total effective rate in the treated group was 78.3%, while that in the control group was 53.3%, comparison of the two groups showed significant difference (P < 0.05). The incidence rate of arrhythmia in the two groups was 18.2% and 30.0% respectively and that of acute myocardial infarction and sudden death was 0 and 5.0% respectively, also showed significant difference between them (P < 0.05). Condition of myocardial ischemia revealed in ECG and partial indexes of heart function in the treated group were all improved to certain extent. Conclusion DS combined with TMZ is superior in treating SUAP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248238

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Compound danshen dripping pills combined with trimetazidine in treating unstable angina pectoris: Protocol for a systematic review of randomized controlled trials.

Authors:  Dongfeng Yao; Chuan Wang; Lihua Han; Pan Zhang; Jiping Liu; Bin Wang; Enhu Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

2.  Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.

Authors:  Yu-Chiang Hung; Yu-Chen Cheng; Chih-Hsin Muo; Hsienhsueh Elley Chiu; Chun-Ting Liu; Wen-Long Hu
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.